Millions of Americans suffer from the effects of type 2 diabetes. It is estimated that over 1.5 million Americans are diagnosed with diabetes each and every year. Many of those diagnosed with diabetes will often need to take powerful medications, including Invokana®.
Although millions of Americans have been prescribed Invokana®, the drug is now coming under fire from lawsuits that allege that the drug causes gangrene, amputations, life-threatening infections, and more in patients.
Millions of Americans suffer from the effects of type 2 diabetes. It is estimated that over 1.5 million Americans are diagnosed with diabetes each and every year. Many of those diagnosed with diabetes will often need to take powerful medications, including Invokana®.
Although millions of Americans have been prescribed Invokana®, the drug is now coming under fire from lawsuits that allege that the drug causes gangrene, amputations, life-threatening infections, and more in patients.
What is Invokana®?
First approved by the FDA for public use in 2013, Invokana® is a SGLT2 inhibitor Type 2 diabetes drug. Invokana®, also known as canagliflozin, work by blocking the kidney's ability to absorb most of the sugar in a person's bloodstream. Instead, the drug made it so that patients can flush out excess sugars through their urine.
The drugs parent company, Janssen Pharmaceuticals® (a subsidiary of Johnson & Johnson®), however, is now being accused of failing to warn patients of the adverse side effects their drug carries. This had led several patients to suffer from side effects they were not aware of.
Find Out If You Are Eligible
Enter Your Phone Number To Start A Free Case Evaluation
Why Lawsuits Now?
Many of those who were prescribed Invokana® for the treatment of their Type 2 diabetes have suffered severe adverse side effects as a result of taking the drug. Because Invokana® functions through the kidneys, patients who take the drug may experience significant dehydration, which can lead to dangerous consequences especially in those with diabetes.
This dehydration can compromise blood flow to the arms, legs, and feet. For many patients suffering from diabetes, limited blood flow could lead to amputations. In 2016, the FDA responded to these adverse effects by issuing a warning regarding the effects of the drug through research that was conducted.
The study found an increased chance of having a leg or foot amputated while on the drug. Patients were never informed of these life-changing side effects until the FDA released a public warning, sparking an outcry from patients.
In May of 2017, the FDA required Janssen Pharmaceuticals® to issue “Black Box” warnings on all Invokana® prescriptions, which are the most significant labeling change that can be ordered by a federal agency. The goal of the FDA was to educate patients to notify their doctors if they developed any symptoms that could lead to an amputation, such as pain, sores, and ulcers.
The FDA also warned the public about cases of patients taking Invokana® who also suffered from serious infections of the genitals and around the genital area. This serious infection is called gangrene.
Some of the symptoms associated with Invokana® can include:
- Amputations
- Kidney Failure
- Gangrene
Final Note
Invokana® is a dangerous drug and can lead to significant adverse side effects such as amputation of the limbs and gangrene. If you or a loved one have taken Invokana® and suffered from adverse side effects, the team at USA Consumer Network can help. Let us connect you with a 100% free attorney to see if you are eligible to file for compensation.
Free Case Evaluations
Let us connect you with a 100% free attorney to see if you are eligible to file for compensation.
This Website is not intended to provide medical advice. Consult your doctor or physician before starting or stopping any medication. This advertisement is not associated with Involana® or Janssen Pharmaceuticals®, a product manufacturing company, or any government agency.